LSE:MDC (Mediclinic International plc)

About MDC

Mediclinic International is a private hospital group with operations in South Africa, Namibia, Switzerland and the United Arab Emirates. Mediclinic was previously just a South African listed company, but it joined the London market in early 2016 with the reverse takeover of Al Noor Hospitals Group.
  • Mediclinic International plc (LSE: MDC) Latest News

    Investing Articles

    Why I’d sell this turnaround stock to buy a ‘secret’ FTSE 100 growth stock

    From small-caps to the FTSE 100 (INDEXFTSE: UKX), there are growth opportunities to be found everywhere.

    Read more »

    Investing Articles

    Why I’d buy this dividend stock over Barclays plc

    Barclays plc's (LON: BARC) dividend potential is limited. This stock is a better buy.

    Read more »

    Investing Articles

    Why I’d sell this FTSE 100 growth stock for its rival’s big dividend

    This growth stock's lofty valuation has me looking at its FTSE 100 (INDEXFTSE: UKX) peer's 3.9% yield and more reasonable…

    Read more »

    Investing Articles

    2 FTSE 100 growth stocks you can retire on

    These two defensive growth champions could be great investments for retirement.

    Read more »

    Investing Articles

    2 super growth stocks you need to check out today

    Royston Wild considers the growth outlook of two mid-week newsmakers.

    Read more »

    Investing Articles

    Is Mediclinic International plc a screaming buy as shares surge 20% higher?

    Regulatory rollbacks send shares of Mediclinic International plc (LON: MDC) soaring 20%. Time to buy?

    Read more »

    Investing Articles

    2 growth stars set to beat the FTSE 100

    These two companies appear to have relatively low valuations given their growth prospects.

    Read more »

    Investing Articles

    Could South Africa’s junk status trash these 3 stocks?

    Troubles in South Africa have hit home for these three UK-listed stocks, says Harvey Jones.

    Read more »

    Investing Articles

    4 stocks I’d buy near 52-week lows

    The only way is up for these for bottom scrapers, says Harvey Jones.

    Read more »

    Investing Articles

    Over 15% upside by 2019 despite profit warning sending this stock 7% lower

    This stock could be worth buying even after a profit warning.

    Read more »

    Investing Articles

    Beat the January sales with these blue-chip bargains

    Bilaal Mohamed spots two blue-chip bargains that could post healthy gains in 2017.

    Read more »

    Investing Articles

    These FTSE 100 stocks sank in Q4. Can they rebound in 2017?

    Royston Wild considers the share price outlook of two FTSE 100 (INDEXFTSE: UKX) crashers.

    Read more »